Chang HM - Search Results

1

Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution.

Chiu JH, Chang HM, Kao HL, Wu LH, Lui WY. Chiu JH, et al. Among authors: chang hm. Cancer Detect Prev. 1996;20(1):43-51. Cancer Detect Prev. 1996. PMID: 8907202

2

Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry.

Chiu JH, Kao HL, Wu LH, Chang HM, Lui WY. Chiu JH, et al. Among authors: chang hm. J Clin Invest. 1992 Feb;89(2):539-45. doi: 10.1172/JCI115618. J Clin Invest. 1992. PMID: 1310697 Free PMC article.

3

Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?

Chiu JH, Wu LH, Kao HL, Chang HM, Tsay SH, Loong CC, Chau GY, Lui WY. Chiu JH, et al. Among authors: chang hm. Hepatology. 1993 Jul;18(1):96-102. Hepatology. 1993. PMID: 8392030

4

Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.

Chiu JH, Lui WY, Chang HM, Loong CC, Wu LH, Kao HL, Wu CW. Chiu JH, et al. Among authors: chang hm. Cytometry. 1997 Dec 15;30(6):317-23. Cytometry. 1997. PMID: 9440824

5

Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.

Chen JH, Wu CW, Kao HL, Chang HM, Li AF, Liu TY, Chi CW. Chen JH, et al. Among authors: chang hm. Cancer Lett. 2006 Aug 8;239(2):263-70. doi: 10.1016/j.canlet.2005.08.026. Epub 2005 Oct 21. Cancer Lett. 2006. PMID: 16243430

6

Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer.

Tseng LM, Hsu CY, Wang HC, Liu JM, Chang HM, Lo SS, Wu CW, Lui WY, Chi CW. Tseng LM, et al. Among authors: chang hm. Anticancer Res. 2001 May-Jun;21(3C):2163-70. Anticancer Res. 2001. PMID: 11501841

7

The nontransformed progesterone and estrogen receptors in gastric cancer.

Wu CW, Chang HM, Kao HL, Lui WY, P'eng FK, Chi CW. Wu CW, et al. Among authors: chang hm. Gastroenterology. 1992 May;102(5):1639-46. doi: 10.1016/0016-5085(92)91724-i. Gastroenterology. 1992. PMID: 1373695

8

Clinicopathologic comparisons between estrogen receptor-positive and -negative gastric cancers.

Wu CW, Tsay SH, Chang TJ, Chang HM, Hsieh MC, Lui WY, P'eng FK, Chi CW. Wu CW, et al. Among authors: chang tj, chang hm. J Surg Oncol. 1992 Dec;51(4):231-5. doi: 10.1002/jso.2930510406. J Surg Oncol. 1992. PMID: 1434653

9

Effects of clodronate on cancer growth and Ca2+ signaling of human thyroid carcinoma cell lines.

Yang DM, Chi CW, Chang HM, Wu LH, Lee TK, Lin JD, Chen ST, Lee CH. Yang DM, et al. Among authors: chang hm. Anticancer Res. 2004 May-Jun;24(3a):1617-23. Anticancer Res. 2004. PMID: 15274331 Free article.

10

Multitest skin testing values of cell-mediated immunity among healthy individuals in Taiwan.

Chang HM, Shann TY, Mok KT, Lui WY, P'eng FK, Lin HY. Chang HM, et al. Zhonghua Yi Xue Za Zhi (Taipei). 1989 Aug;44(2):81-8. Zhonghua Yi Xue Za Zhi (Taipei). 1989. PMID: 2819579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

873 results

Search Page

Filters